Clinical Trial Update: The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of adding probiotics to rifaximin for treating small intestinal bacterial overgrowth in irritable bowel syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Small Interstitial Bacterial Overgrowth

Drugs mentioned

• Probiotic (unspecified)
• Rifaximin (rifaximin)

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: Irritable Bowel Syndrome, Small Intestinal Bacterial Overgrowth | NA | Status: COMPLETED